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Background
Data from research, clinics and response to treatment
point out to an autoinflammatory pathogenesis in Sys-
temic onset Juvenile Idiopathic Arthritis (SoJIA). How-
ever a subgroup of patients present with chronic active
course of disease, destructive polyarthritis and produc-
tion of autoantibodies (CAPA-subtype) not responsive
to anti IL-1 treatment.
Aim
Determine phenotypic characteristics of the CAPA-sub-
type of SoJIA.
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SoJIA-Patients 35
Observation (month) mean 69 (range 1-262)
n% n %
Autoantibodies pos neg
9 25,7 26 74,3
ANA 6 17,1
RF 2 5,7
ANCA 3 8,6
percentage for each group
male 3 33,3 11 42,3
female 6 66,6 15 57,7
onset age (years) 6,03 3,54
relapses 4 3,6
joints at onset 2,1 3,1
joints when AK pos 7
MAS 1 1
Carditis 6 66,7 13 50
S A A 2o f4 8o f1 2
Amyloidosis 1 1
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Retrospective analysis in a cohort of 35 SoJIA patients
well characterized according clinical course and ANA,
Rheumatic factor and ANCA.
Results
Autoantibodies have been found in 25,7% of the
patients, with ANA being the most frequent auto-AK
(table 1). There was a significant difference according
the age of onset. Moreover females and carditis have
been observed more frequently in the AK-pos. group.
Conclusion
There is evidence for an autoimmune course of disease
in SoJIA in a subset of patients with chronic polyarthri-
tis but without relapses of autoinflammation. These
patients probably will need a switch in treatment to pre-
vent further joint destruction.
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